# ANK1

## Overview
The ANK1 gene encodes ankyrin 1, a crucial cytoskeletal protein that plays a significant role in maintaining cellular structure by linking integral membrane proteins to the cytoskeleton. Ankyrin 1 is categorized as a modular protein, comprising distinct domains that facilitate its interaction with various cellular components, including the spectrin-actin cytoskeleton. This protein is essential for the structural integrity and mechanical stability of erythrocyte membranes, contributing to their biconcave shape and resilience under circulatory stress (Bennett1992Ankyrins.; Birkenmeier1993Complex). Beyond erythrocytes, ankyrin 1 is expressed in neurons, myocardium, and skeletal muscles, where it exists in multiple isoforms due to alternative splicing. These isoforms are involved in diverse cellular functions, including neuronal activity regulation and muscle cell organization (Chagula2020Ankyrins; Omura2016Overexpression). Mutations in the ANK1 gene are implicated in hereditary spherocytosis, a condition characterized by hemolytic anemia, underscoring the gene's clinical significance (Perrotta2008Hereditary).

## Structure
The ANK1 gene encodes the ankyrin-1 protein, which plays a crucial role in linking integral membrane proteins to the cytoskeleton. Ankyrin-1 is a modular protein composed of three main domains: an N-terminal membrane-binding domain, a central spectrin-binding domain, and a C-terminal regulatory domain (Ipsaro2009Structures; Birkenmeier1993Complex). The N-terminal domain contains ankyrin repeats, which are 33-amino acid motifs involved in protein-protein interactions (Bennett1992Ankyrins.). The spectrin-binding domain includes a ZU5 subdomain, which is essential for binding to spectrin (Ipsaro2009Structures).

The tertiary structure of ankyrin-1 features a compact, well-folded core rich in β-sheets, with two antiparallel β-sheets forming the core structure (Ipsaro2009Structures). The ZU5-ANK domain displays a conserved, positively charged surface patch, suggesting a similar charged surface across ankyrin isoforms (Ipsaro2009Structures).

Ankyrin-1 undergoes alternative splicing, resulting in multiple isoforms with varying functions and tissue-specific expressions (Birkenmeier1993Complex). Post-translational modifications, such as phosphorylation, can regulate its function, although specific modifications are not detailed in the provided context. The protein's structure and interactions are critical for maintaining the integrity of the erythrocyte cytoskeleton and other cellular functions.

## Function
The ANK1 gene encodes ankyrin-R, a protein that plays a critical role in maintaining the structural integrity of erythrocyte membranes by linking integral membrane proteins to the spectrin-actin cytoskeleton. This interaction is essential for the biconcave shape and mechanical stability of red blood cells, allowing them to withstand shear forces during circulation (Hao2019Two; Sharma2020Human). Ankyrin-R is the only ankyrin expressed in erythrocytes and is crucial for the stability of the Rh complex, which is vital for proper erythrocyte function (Chagula2020Ankyrins).

In addition to its role in erythrocytes, ankyrin-R is expressed in neurons, myocardium, and skeletal muscles, where it exists in various isoforms. In neurons, particularly in the cerebellum, ankyrin-R localizes to Purkinje and granule cells, forming complexes with β-III spectrin to maintain sodium levels and neuronal activity (Chagula2020Ankyrins). The protein is also involved in cellular signaling and structural stability through its interactions with cell surface receptors and other proteins (Omura2016Overexpression). Ankyrin-R's function is crucial for the normal physiology and function of neuronal and epithelial membranes (Chagula2020Ankyrins).

## Clinical Significance
Mutations in the ANK1 gene are a common cause of hereditary spherocytosis (HS), a hemolytic anemia characterized by the presence of sphere-shaped red blood cells. These mutations disrupt the structural integrity of erythrocyte membranes, leading to decreased membrane surface area and increased osmotic fragility, which causes the red blood cells to be more prone to hemolysis (Perrotta2008Hereditary; He2018Molecular). The genetic pattern of ANK1 mutations in HS is predominantly autosomal dominant, although autosomal recessive inheritance has also been observed (He2018Molecular). 

The ANK1 c.1504-9G>A mutation, identified in Han Chinese patients, leads to intron retention and abnormal splicing, resulting in a truncated protein and reduced expression of the ANK1 gene. This mutation is classified as likely pathogenic and contributes to the pathogenesis of hereditary spherocytosis by affecting normal splicing and protein expression (Xiong2024Identification). 

In addition to its role in HS, alterations in ANK1 expression or interactions have been linked to neurological disturbances, including cerebellar defects and spinal cord disease, although HS itself is not a neurological condition (Stevens2021Ankyrins).

## Interactions
ANK1 (ankyrin 1) is involved in various protein interactions that are crucial for its function in cellular structures. In tobacco, the ANK1 protein interacts with the bZIP transcription factor BZI-1. This interaction occurs through the D1 domain of BZI-1, although other regions also contribute. ANK1 does not bind DNA directly but can inhibit the DNA binding of BZI-1, suggesting a role in modulating transcriptional activity (Kuhlmann2003The).

In skeletal muscle, ANK1 isoforms, particularly small ankyrin 1 (sAnk1), interact with obscurin, a large scaffolding protein. This interaction is mediated by specific domains in both proteins and is essential for the localization of the sarcoplasmic reticulum (SR) in muscle cells. The binding of sAnk1 to obscurin is characterized by electrostatic interactions, with key residues such as R69, R104, and K105 on sAnk1 playing significant roles (Busby2011Electrostatic). The interaction between sAnk1 and obscurin is crucial for the structural organization of the SR and the contractile apparatus in muscle fibers (KontrogianniKonstantopoulos2003Obscurin; Armani2006Molecular). These interactions highlight ANK1's role in maintaining cellular architecture and function.


## References


[1. (Armani2006Molecular) Andrea Armani, Sara Galli, Emiliana Giacomello, Paola Bagnato, Virginia Barone, Daniela Rossi, and Vincenzo Sorrentino. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum. Experimental Cell Research, 312(18):3546–3558, November 2006. URL: http://dx.doi.org/10.1016/j.yexcr.2006.07.027, doi:10.1016/j.yexcr.2006.07.027. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2006.07.027)

[2. (Perrotta2008Hereditary) Silverio Perrotta, Patrick G Gallagher, and Narla Mohandas. Hereditary spherocytosis. The Lancet, 372(9647):1411–1426, October 2008. URL: http://dx.doi.org/10.1016/s0140-6736(08)61588-3, doi:10.1016/s0140-6736(08)61588-3. This article has 451 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0140-6736(08)61588-3)

[3. (Busby2011Electrostatic) Ben Busby, Taiji Oashi, Chris D. Willis, Maegen A. Ackermann, Aikaterini Kontrogianni-Konstantopoulos, Alexander D. MacKerell, and Robert J. Bloch. Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies. Journal of Molecular Biology, 408(2):321–334, April 2011. URL: http://dx.doi.org/10.1016/j.jmb.2011.01.053, doi:10.1016/j.jmb.2011.01.053. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2011.01.053)

[4. (He2018Molecular) Ben-Jin He, Lin Liao, Zeng-Fu Deng, Yi-Feng Tao, Yu-Chan Xu, and Fa-Quan Lin. Molecular genetic mechanisms of hereditary spherocytosis: current perspectives. Acta Haematologica, 139(1):60–66, 2018. URL: http://dx.doi.org/10.1159/000486229, doi:10.1159/000486229. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1159/000486229)

[5. (Stevens2021Ankyrins) Sharon R Stevens and Matthew N Rasband. Ankyrins and neurological disease. Current Opinion in Neurobiology, 69:51–57, August 2021. URL: http://dx.doi.org/10.1016/j.conb.2021.01.002, doi:10.1016/j.conb.2021.01.002. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.conb.2021.01.002)

[6. (Omura2016Overexpression) Noriyuki Omura, Masamichi Mizuma, Anne MacGregor, Seung-Mo Hong, Michael Ayars, Jose Alejandro Almario, Michael Borges, Mitsuro Kanda, Ang Li, Audrey Vincent, Anirban Maitra, and Michael Goggins. Overexpression of ankyrin1 promotes pancreatic cancer cell growth. Oncotarget, 7(23):34977–34987, April 2016. URL: http://dx.doi.org/10.18632/oncotarget.9009, doi:10.18632/oncotarget.9009. This article has 15 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.9009)

[7. (Hao2019Two) Lili Hao, Shanshan Li, Duan Ma, Shiyu Chen, Bowen Zhang, Deyong Xiao, Jin Zhang, Nan Jiang, Shayi Jiang, and Jing Ma. Two novel ank1 loss‐of‐function mutations in chinese families with hereditary spherocytosis. Journal of Cellular and Molecular Medicine, 23(6):4454–4463, April 2019. URL: http://dx.doi.org/10.1111/jcmm.14343, doi:10.1111/jcmm.14343. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.14343)

[8. (Bennett1992Ankyrins.) V Bennett. Ankyrins. adaptors between diverse plasma membrane proteins and the cytoplasm. Journal of Biological Chemistry, 267(13):8703–8706, May 1992. URL: http://dx.doi.org/10.1016/s0021-9258(19)50333-7, doi:10.1016/s0021-9258(19)50333-7. This article has 209 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(19)50333-7)

[9. (Ipsaro2009Structures) Jonathan J. Ipsaro, Lei Huang, and Alfonso Mondragón. Structures of the spectrin-ankyrin interaction binding domains. Blood, 113(22):5385–5393, May 2009. URL: http://dx.doi.org/10.1182/blood-2008-10-184358, doi:10.1182/blood-2008-10-184358. This article has 79 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2008-10-184358)

[10. (Kuhlmann2003The) Markus Kuhlmann, Katja Horvay, Anne Strathmann, Thorsten Heinekamp, Ute Fischer, Stefan Böttner, and Wolfgang Dröge-Laser. The α-helical d1 domain of the tobacco bzip transcription factor bzi-1 interacts with the ankyrin-repeat protein ank1 and is important for bzi-1 function, both in auxin signaling and pathogen response. Journal of Biological Chemistry, 278(10):8786–8794, March 2003. URL: http://dx.doi.org/10.1074/JBC.M210292200, doi:10.1074/jbc.m210292200. This article has 71 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M210292200)

[11. (KontrogianniKonstantopoulos2003Obscurin) Aikaterini Kontrogianni-Konstantopoulos, Ellene M. Jones, Damian B. van Rossum, and Robert J. Bloch. Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Molecular Biology of the Cell, 14(3):1138–1148, March 2003. URL: http://dx.doi.org/10.1091/mbc.e02-07-0411, doi:10.1091/mbc.e02-07-0411. This article has 157 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e02-07-0411)

[12. (Birkenmeier1993Complex) C.S. Birkenmeier, R.A. White, L.L. Peters, E.J. Hall, S.E. Lux, and J.E. Barker. Complex patterns of sequence variation and multiple 5‘ and 3‘ ends are found among transcripts of the erythroid ankyrin gene. Journal of Biological Chemistry, 268(13):9533–9540, May 1993. URL: http://dx.doi.org/10.1016/s0021-9258(18)98384-5, doi:10.1016/s0021-9258(18)98384-5. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)98384-5)

[13. (Chagula2020Ankyrins) Damian Chagula, Tomasz Rechciński, Karolina Rudnicka, and Magdalena Chmiela. Ankyrins in human health and disease – an update of recent experimental findings. Archives of Medical Science, 16(4):715–726, 2020. URL: http://dx.doi.org/10.5114/aoms.2019.89836, doi:10.5114/aoms.2019.89836. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.5114/aoms.2019.89836)

[14. (Xiong2024Identification) Ting Xiong, Zhongjin Xu, Qian Wan, Feng Chen, Yao Ye, Hong Wang, and Chongjun Wu. Identification of a novel ank1 gene variant c.1504-9g&gt;a and its mechanism of intron retention in hereditary spherocytosis. Frontiers in Genetics, April 2024. URL: http://dx.doi.org/10.3389/fgene.2024.1390924, doi:10.3389/fgene.2024.1390924. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2024.1390924)

[15. (Sharma2020Human) Nidhi Sharma, Kamlesh Bham, and Sabyasachi Senapati. Human ankyrins and their contribution to disease biology: an update. Journal of Biosciences, November 2020. URL: http://dx.doi.org/10.1007/s12038-020-00117-3, doi:10.1007/s12038-020-00117-3. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12038-020-00117-3)